BE790440A
(pt)
|
1971-10-23 |
1973-04-24 |
Bayer Ag |
|
JPS50106981U
(pt)
|
1974-02-08 |
1975-09-02 |
|
|
US3906953A
(en)
|
1974-05-23 |
1975-09-23 |
American Optical Corp |
Endoscopic surgical laser system
|
SU509578A1
(ru)
|
1974-09-19 |
1976-04-05 |
Стерлитамакский Химический Завод |
Способ получени пропилендиаминов
|
IE43079B1
(en)
|
1975-03-20 |
1980-12-17 |
Ici Ltd |
Quinolone derivatives
|
GB1502312A
(en)
|
1975-03-20 |
1978-03-01 |
Ici Ltd |
Quinolone derivatives
|
FR2311776A1
(fr)
|
1975-05-23 |
1976-12-17 |
Sogeras |
Diamino-2,4 bromo-5 chloro-6 pyrimidines et procede pour leur preparation
|
GB1570494A
(en)
|
1975-11-28 |
1980-07-02 |
Ici Ltd |
Thienopyrimidine derivatives and their use as pesticides
|
JPS5382783U
(pt)
|
1976-12-13 |
1978-07-08 |
|
|
JPS5752334Y2
(pt)
|
1977-03-16 |
1982-11-13 |
|
|
ZA782648B
(en)
|
1977-05-23 |
1979-06-27 |
Ici Australia Ltd |
The prevention,control or eradication of infestations of ixodid ticks
|
DE2750288A1
(de)
|
1977-11-10 |
1979-05-17 |
Thomae Gmbh Dr K |
Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
|
US4432979A
(en)
|
1981-10-26 |
1984-02-21 |
William H. Rorer, Inc. |
Pyridone compounds
|
EP0082023A3
(en)
|
1981-12-16 |
1983-07-20 |
Sankyo Company Limited |
Thienopyrimidine derivatives, their preparation and their medical use
|
US4358453A
(en)
|
1982-01-08 |
1982-11-09 |
Schering Corporation |
1,2,4-Triazolo[4,3-a]pyridines
|
US4520025A
(en)
|
1982-07-21 |
1985-05-28 |
William H. Rorer, Inc. |
Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
|
DE3406329A1
(de)
|
1984-02-22 |
1985-08-22 |
Merck Patent Gmbh, 6100 Darmstadt |
Pyridone
|
US4550166A
(en)
|
1984-05-21 |
1985-10-29 |
American Cyanamid Company |
(Pyridinyl)-1,2,4-triazolo[4,3-a]pyridines
|
DE3717561A1
(de)
|
1987-05-25 |
1988-12-08 |
Thomae Gmbh Dr K |
Indol-, isochinolin- und benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
US5175157A
(en)
|
1985-11-27 |
1992-12-29 |
Boehringer Ingelheim Gmbh |
Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
|
US4866074A
(en)
|
1987-05-08 |
1989-09-12 |
Rorer Pharmaceutical Corporation |
Naphtheridinone- and pyridooxazinone-pyridone compounds, cardiotonic compositions including same, and their uses
|
EP0308020A3
(en)
|
1987-09-18 |
1990-12-05 |
Merck & Co. Inc. |
5-(aryl and heteroaryl)-6-(aryl and heteroaryl)-1,2-dihydro-2-oxo 3-pyridinecarboxylic acids and derivatives thereof
|
US5260293A
(en)
|
1988-01-30 |
1993-11-09 |
Merck Sharp & Dohme Limited |
Pyrazines, pyrimidines and pyridazines useful in the treatment of senile dementia
|
GB8804448D0
(en)
|
1988-02-25 |
1988-03-23 |
Smithkline Beckman Intercredit |
Compounds
|
JP2614081B2
(ja)
|
1988-05-27 |
1997-05-28 |
大塚化学株式会社 |
光学活性β−ラクタム誘導体の製造法
|
ES2075071T3
(es)
|
1988-10-20 |
1995-10-01 |
Sandoz Ag |
Colorantes azoicos reactivos con fibras.
|
US5032602A
(en)
|
1988-12-14 |
1991-07-16 |
Bayer Aktiengesellschaft |
Inhibiting HMG-CoA reductase with novel substituted 2-pyridones and pyrid-2-thiones
|
HU206337B
(en)
|
1988-12-29 |
1992-10-28 |
Mitsui Petrochemical Ind |
Process for producing pyrimidine derivatives and pharmaceutical compositions
|
US5236917A
(en)
|
1989-05-04 |
1993-08-17 |
Sterling Winthrop Inc. |
Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
|
US5280026A
(en)
|
1989-05-30 |
1994-01-18 |
Smithkline Beecham Intercredit B.V. |
Thienopyrimidines
|
AU622330B2
(en)
|
1989-06-23 |
1992-04-02 |
Takeda Chemical Industries Ltd. |
Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
|
US4978663A
(en)
|
1989-08-16 |
1990-12-18 |
Hoechst-Roussel Pharmaceuticals Inc. |
5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility
|
GB8926560D0
(en)
|
1989-11-24 |
1990-01-17 |
Zambeletti Spa L |
Pharmaceuticals
|
IL96432A0
(en)
|
1989-11-30 |
1991-08-16 |
Schering Ag |
Pesticidal compositions containing pyridine derivatives and novel pyridine derivatives
|
DE3940480A1
(de)
|
1989-12-07 |
1991-06-13 |
Bayer Ag |
Chromogene enaminverbindungen, ihre herstellung und verwendung als farbbildner
|
WO1991009848A1
(en)
|
1989-12-22 |
1991-07-11 |
The Upjohn Company |
Pyridinones useful as antiatherosclerotic agents
|
FR2657610A1
(fr)
|
1990-01-29 |
1991-08-02 |
Rhone Poulenc Agrochimie |
Triazolopyridines herbicides.
|
GB9104238D0
(en)
|
1990-03-16 |
1991-04-17 |
Ici Pharma |
3-tetrazolylthiomethyl cephalosporin antibiotics
|
DE4008726A1
(de)
|
1990-03-19 |
1991-09-26 |
Basf Ag |
Thieno(2,3-d)pyrimidinderivate
|
CA2039411A1
(en)
|
1990-03-30 |
1991-10-01 |
Ronnie Gerald Edie |
Thienopyrimidine derivatives
|
RU1796625C
(ru)
|
1990-06-27 |
1993-02-23 |
Киевский Государственный Университет Им.Т.Г.Шевченко |
3-Амино-7-нитро-4(2,3,4-триметоксифенил)-2-фенил-1(2Н)изохинолон, обладающий аналептическим действием
|
ATE180475T1
(de)
|
1990-09-21 |
1999-06-15 |
Rohm & Haas |
Dihydropyridazinone und pyridazinone als fungizide
|
KR920008026A
(ko)
|
1990-10-24 |
1992-05-27 |
오노 화아마슈티칼 캄파니 리미팃드 |
이소퀴놀리논 유도체 또는 이의 무독성 산부가염 또는 이의 수화물, 이의 제조방법 및 이를 포함하는 약제 조성물
|
WO1992018115A1
(en)
|
1991-04-18 |
1992-10-29 |
Dr Lo Zambeletti S.P.A. |
Use of heterocyclic compounds for the treatment of inflammatory pain
|
DE4122240A1
(de)
|
1991-07-05 |
1993-01-07 |
Boehringer Mannheim Gmbh |
Dibenz(b,e)azepinderivate und diese enthaltende arzneimittel
|
US5332750A
(en)
|
1991-09-04 |
1994-07-26 |
Merck Patent Gesellschaft Mit Beschrankter Haftung |
1,2-dihydro-2-oxopyridines
|
DE4129340A1
(de)
|
1991-09-04 |
1993-03-11 |
Merck Patent Gmbh |
1,2-dihydro-2-oxopyridine
|
DE4131924A1
(de)
|
1991-09-25 |
1993-07-08 |
Hoechst Ag |
Substituierte 4-alkoxypyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
|
US5204198A
(en)
|
1991-10-28 |
1993-04-20 |
Eastman Kodak Company |
Photoelectrographic elements utilizing nonionic sulfonic acid photogenerators
|
US5416099A
(en)
|
1991-10-29 |
1995-05-16 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
DE4221583A1
(de)
|
1991-11-12 |
1993-05-13 |
Bayer Ag |
Substituierte biphenylpyridone
|
JP2878531B2
(ja)
|
1991-12-16 |
1999-04-05 |
富士写真フイルム株式会社 |
ハロゲン化銀写真感光材料
|
US5378720A
(en)
|
1991-12-19 |
1995-01-03 |
Sterling Winthrop Inc. |
Saccharin derivative proteolytic enzyme inhibitors
|
AU668694B2
(en)
|
1991-12-19 |
1996-05-16 |
Sanofi-Synthelabo |
Saccharin derivative proteolytic enzyme inhibitors
|
TW219935B
(pt)
|
1991-12-25 |
1994-02-01 |
Mitsubishi Chemicals Co Ltd |
|
GB9200293D0
(en)
|
1992-01-08 |
1992-02-26 |
Wyeth John & Brother Ltd |
Piperazine derivatives
|
GB9201694D0
(en)
|
1992-01-27 |
1992-03-11 |
Smithkline Beecham Intercredit |
Compounds
|
JP3042156B2
(ja)
|
1992-02-20 |
2000-05-15 |
田辺製薬株式会社 |
ナフタレン誘導体、その製法及びその合成中間体
|
DE4206045A1
(de)
|
1992-02-27 |
1993-09-02 |
Bayer Ag |
Sulfonylbenzyl substituierte pyridone
|
US5922773A
(en)
|
1992-12-04 |
1999-07-13 |
The Children's Medical Center Corp. |
Glaucoma treatment
|
AU660132B2
(en)
|
1992-12-21 |
1995-06-08 |
Bayer Aktiengesellschaft |
Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridine
|
SE9300657D0
(sv)
|
1993-02-26 |
1993-02-26 |
Astra Ab |
New compounds
|
US5814645A
(en)
|
1993-03-24 |
1998-09-29 |
Bayer Aktiengesellschaft |
Arylor hetaryl substituted nitrogen heterocycles and their use as pesticides
|
DE4316077A1
(de)
|
1993-05-13 |
1994-11-17 |
Bayer Ag |
Substituierte Mono- und Bihydridylmethylpyridone
|
JPH08511538A
(ja)
|
1993-06-09 |
1996-12-03 |
スミスクライン・ビーチャム・コーポレイション |
二環式フィブリノゲン拮抗物質
|
DE4326758A1
(de)
|
1993-08-10 |
1995-02-16 |
Basf Ag |
[1,3,4]Triazolo[1,5-a]pyridine
|
DE69433401T2
(de)
|
1993-08-19 |
2004-09-16 |
Janssen Pharmaceutica N.V. |
Gefässverengende dihydrobenzopyranderivate
|
KR100345046B1
(ko)
|
1993-08-19 |
2002-12-05 |
얀센 파마슈티카 엔.브이. |
혈관수축성치환된아릴옥시알킬디아민
|
WO1995006032A1
(en)
|
1993-08-20 |
1995-03-02 |
Banyu Pharmaceutical Co., Ltd. |
Tyrosine kinase inhibitor
|
US5424435A
(en)
|
1993-10-18 |
1995-06-13 |
Olin Corporation |
1-hydroxy-6-substituted-2-pyridones
|
US5500420A
(en)
|
1993-12-20 |
1996-03-19 |
Cornell Research Foundation, Inc. |
Metabotropic glutamate receptor agonists in the treatment of cerebral ischemia
|
US5654307A
(en)
|
1994-01-25 |
1997-08-05 |
Warner-Lambert Company |
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
RU2155188C2
(ru)
|
1994-03-10 |
2000-08-27 |
Фудзисава Фармасьютикал Со., Лтд. |
Производные нафталина, фармацевтическая композиция
|
ES2079323B1
(es)
|
1994-06-21 |
1996-10-16 |
Vita Invest Sa |
Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
|
GB9416554D0
(en)
|
1994-08-19 |
1994-10-12 |
Ciba Geigy Ag |
Glutamate receptor
|
WO1996005828A1
(en)
|
1994-08-24 |
1996-02-29 |
Eli Lilly And Company |
Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor antagonists
|
US5473077A
(en)
|
1994-11-14 |
1995-12-05 |
Eli Lilly And Company |
Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists
|
US6017697A
(en)
|
1994-11-14 |
2000-01-25 |
Eli Lilly And Company |
Excitatory amino acid receptor protein and related nucleic acid compounds
|
US5512576A
(en)
|
1994-12-02 |
1996-04-30 |
Sterling Winthrop Inc. |
2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
|
DE4444815A1
(de)
*
|
1994-12-15 |
1996-06-20 |
Merck Patent Gmbh |
Thienopyridone
|
US5789426A
(en)
|
1995-01-20 |
1998-08-04 |
Cornell Research Foundation, Inc. |
Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
|
US5869486A
(en)
|
1995-02-24 |
1999-02-09 |
Ono Pharmaceutical Co., Ltd. |
Fused pyrimidines and pyriazines as pharmaceutical compounds
|
DE19507522C2
(de)
|
1995-03-03 |
2003-05-28 |
Basf Ag |
Verfahren zur Herstellung von 3,4-Dihydroisochinolinverbindungen und 3,4-Dihydroisochinolinium-Salzen
|
US5869428A
(en)
|
1995-03-13 |
1999-02-09 |
Ishihara Sangyo Kaisha Ltd. |
Pyridonesulfonylurea compounds, process for their production and herbicides containing them
|
DE19510965A1
(de)
|
1995-03-24 |
1996-09-26 |
Asta Medica Ag |
Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung
|
WO1996033974A1
(fr)
|
1995-04-27 |
1996-10-31 |
The Green Cross Corporation |
Composes heterocycliques amides et leur utilisation medicinale
|
JPH08325248A
(ja)
|
1995-05-26 |
1996-12-10 |
Chugoku Kayaku Kk |
テトラゾール類の新規な合成試薬及びそれを用いたテトラゾール類の製造方法
|
US5849587A
(en)
|
1995-06-09 |
1998-12-15 |
Cornell Research Foundation, Inc. |
Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells
|
US5659033A
(en)
|
1995-09-13 |
1997-08-19 |
Neurogen Corporation |
N-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands
|
SK282222B6
(sk)
|
1995-09-15 |
2001-12-03 |
Sanofi-Synthelabo |
Deriváty 2(1h)-chinolónu, spôsob ich prípravy a ich použitie ako liečiv
|
JPH1045750A
(ja)
|
1995-09-20 |
1998-02-17 |
Takeda Chem Ind Ltd |
アゾール化合物、その製造方法及び用途
|
US6130217A
(en)
|
1995-09-20 |
2000-10-10 |
Pfizer Inc |
Compounds enhancing antitumor activity of other cytotoxic agents
|
AR004010A1
(es)
|
1995-10-11 |
1998-09-30 |
Glaxo Group Ltd |
Compuestos heterociclicos
|
PT1162201E
(pt)
|
1995-12-08 |
2006-08-31 |
Janssen Pharmaceutica Nv |
Derivados de ( imidazol-5-il ) metil-2-quinolinona como inibidores da proteina farnesil transferase
|
WO1997028128A1
(en)
|
1996-02-02 |
1997-08-07 |
Zeneca Limited |
Heterocyclic compounds useful as pharmaceutical agents
|
GB9602166D0
(en)
|
1996-02-02 |
1996-04-03 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
GB9602294D0
(en)
|
1996-02-05 |
1996-04-03 |
Zeneca Ltd |
Heterocyclic compounds
|
US6084084A
(en)
|
1996-02-21 |
2000-07-04 |
Nps Pharmaceuticals, Inc. |
Human metabotropic glutamate receptor
|
US5710274A
(en)
|
1996-02-28 |
1998-01-20 |
Neurogen Corporation |
N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands
|
US5756518A
(en)
|
1996-04-02 |
1998-05-26 |
Kowa Co., Ltd. |
Phenylene derivatives
|
JPH1029979A
(ja)
|
1996-04-12 |
1998-02-03 |
Ajinomoto Co Inc |
新規ピリジン誘導体
|
US5741798A
(en)
|
1996-06-03 |
1998-04-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
2-benzyl-4-sulfonyl-4H-isoquinolin-1,3-diones and their use as antiinflammatory agents
|
WO1998006724A1
(fr)
|
1996-08-09 |
1998-02-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Agonistes du recepteur du glutamate metabotropique
|
DE19632423A1
(de)
|
1996-08-12 |
1998-02-19 |
Merck Patent Gmbh |
Thienopyrimidine
|
AU3701797A
(en)
|
1996-08-14 |
1998-03-06 |
Zeneca Limited |
Substituted pyrimidine derivatives and their pharmaceutical use
|
US6159980A
(en)
|
1996-09-16 |
2000-12-12 |
Dupont Pharmaceuticals Company |
Pyrazinones and triazinones and their derivatives thereof
|
DE19638486A1
(de)
|
1996-09-20 |
1998-03-26 |
Basf Ag |
Hetaroylderivate
|
DE19638484A1
(de)
|
1996-09-20 |
1998-03-26 |
Basf Ag |
Hetaroylderivate
|
DE19644228A1
(de)
|
1996-10-24 |
1998-04-30 |
Merck Patent Gmbh |
Thienopyrimidine
|
US6284794B1
(en)
|
1996-11-05 |
2001-09-04 |
Head Explorer Aps |
Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
|
WO1998024780A2
(en)
|
1996-12-05 |
1998-06-11 |
Amgen Inc. |
Substituted pyrimidinone and pyridinone compounds and their use
|
DE69812934T2
(de)
|
1997-01-24 |
2004-01-29 |
Conpharma As Oslo |
Gemcitabin-derivate
|
US5855654A
(en)
|
1997-01-30 |
1999-01-05 |
Rohm And Haas Company |
Pyridazinones as marine antifouling agents
|
FR2759366B1
(fr)
|
1997-02-11 |
1999-04-16 |
Centre Nat Rech Scient |
Composes constituant notamment des effecteurs de recepteurs du systeme nerveux central sensibles aux amino acides neuroexcitateurs, leur preparation et leurs applications biologiques
|
US6262068B1
(en)
|
1997-02-21 |
2001-07-17 |
Bristol-Myers Squibb Company |
Lactam derivatives as antiarrhythmic agents
|
AU6230098A
(en)
|
1997-02-27 |
1998-09-18 |
Tanabe Seiyaku Co., Ltd. |
Isoquinolinone derivatives, process for preparing the same, and their use as phosphodiesterase inhibitors
|
ES2131463B1
(es)
|
1997-04-08 |
2000-03-01 |
Lilly Sa |
Derivados de ciclopropilglicina con propiedades farmaceuticas.
|
GB9708945D0
(en)
|
1997-05-01 |
1997-06-25 |
Merck Sharp & Dohme |
Therapeutic agents
|
DE19728996A1
(de)
|
1997-07-07 |
1999-01-14 |
Basf Ag |
Triazolverbindungen und deren Verwendung
|
ATE214704T1
(de)
|
1997-07-18 |
2002-04-15 |
Hoffmann La Roche |
5h-thiazolo(3,2-a)pyrimidinderivate
|
EP1000015A1
(en)
|
1997-07-18 |
2000-05-17 |
Georgetown University |
Bicyclic metabotropic glutamate receptor ligands
|
CA2295295A1
(en)
|
1997-07-31 |
1999-02-11 |
Celgene Corporation |
Substituted alkanohydroxamic acids and method of reducing tnf.alpha. levels
|
YU6100A
(sh)
|
1997-08-14 |
2002-10-18 |
F.Hoffmann-La Roche Ag. |
Heterociklični viniletri protiv neuroloških poremećaja
|
US6358975B1
(en)
|
1997-08-15 |
2002-03-19 |
Johns Hopkins University |
Method of using selective parp inhibitors to prevent or treat neurotoxicity
|
AU9298098A
(en)
|
1997-09-03 |
1999-03-22 |
Guilford Pharmaceuticals Inc. |
Amino-substituted compounds, methods, and compositions for inhibiting parp activity
|
US6197785B1
(en)
|
1997-09-03 |
2001-03-06 |
Guilford Pharmaceuticals Inc. |
Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity
|
US20020022636A1
(en)
|
1997-09-03 |
2002-02-21 |
Jia-He Li |
Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
|
US6121278A
(en)
|
1997-09-03 |
2000-09-19 |
Guilford Pharmaceuticals, Inc. |
Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
|
US6635642B1
(en)
|
1997-09-03 |
2003-10-21 |
Guilford Pharmaceuticals Inc. |
PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same
|
US20020028813A1
(en)
|
1997-09-03 |
2002-03-07 |
Paul F. Jackson |
Thioalkyl compounds, methods, and compositions for inhibiting parp activity
|
AU9740998A
(en)
|
1997-09-08 |
1999-03-29 |
F. Hoffmann-La Roche Ag |
Piperidine derivatives against malaria
|
ES2200248T3
(es)
|
1997-09-19 |
2004-03-01 |
Ssp Co., Ltd. |
Derivados de acudi fenilpropionico sustituido en alfa y medicamento que los contienen.
|
WO1999016755A1
(en)
|
1997-09-26 |
1999-04-08 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
US6465484B1
(en)
|
1997-09-26 |
2002-10-15 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
US6162804A
(en)
|
1997-09-26 |
2000-12-19 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
EP1019391A1
(en)
|
1997-10-02 |
2000-07-19 |
Merck & Co. Inc. |
Inhibitors of prenyl-protein transferase
|
JP3329337B2
(ja)
|
1997-10-14 |
2002-09-30 |
三菱ウェルファーマ株式会社 |
ピペラジン化合物およびその医薬としての用途
|
WO1999021992A2
(en)
|
1997-10-23 |
1999-05-06 |
Ganimed Pharmaceuticals Gmbh |
Nucleic acid molecules encoding a glutamate receptor
|
WO1999031062A1
(fr)
|
1997-12-17 |
1999-06-24 |
Shionogi & Co., Ltd. |
Nouveaux composes de pyridine
|
US6013672A
(en)
|
1997-12-18 |
2000-01-11 |
Uab Research Foundation |
Agonists of metabotropic glutamate receptors and uses thereof
|
EP1045836B1
(en)
|
1997-12-18 |
2008-03-05 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Pyridones as src family sh2 domain inhibitors
|
KR20010033241A
(ko)
|
1997-12-19 |
2001-04-25 |
스티븐 엠. 오드레 |
치환된 피리딘 및 피리다진 화합물과 그것의 제약학적 용도
|
FR2772763B1
(fr)
|
1997-12-24 |
2004-01-23 |
Sod Conseils Rech Applic |
Nouveaux analogues tetracycliques de camptothecines, leurs procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
|
IT1298155B1
(it)
|
1998-01-19 |
1999-12-20 |
Moreno Paolini |
Composti pirimidin 3-ossido per il trattamento delle patologie muscolo-scheletriche, in particolare per il trattamento della
|
US6664250B2
(en)
|
1998-01-20 |
2003-12-16 |
Bristol-Myers Squibb Co. |
Lactam derivatives as antiarrhythmic agents
|
WO1999038839A1
(fr)
|
1998-01-28 |
1999-08-05 |
Taisho Pharmaceutical Co., Ltd. |
Derives d'acides amines renfermant du fluor
|
AU748087B2
(en)
|
1998-02-17 |
2002-05-30 |
Tularik Inc. |
Anti-viral pyrimidine derivatives
|
PT1064256E
(pt)
|
1998-03-17 |
2004-10-29 |
Pfizer Prod Inc |
Biciclo[2.2.1] heptanos e compostos relacionados
|
EP1076655A1
(en)
|
1998-04-08 |
2001-02-21 |
Novartis AG |
N-pyridonyl herbicides
|
AU3170099A
(en)
|
1998-04-16 |
1999-11-08 |
Yamanouchi Pharmaceutical Co., Ltd. |
Remedies for obesity
|
EP0955301A3
(en)
|
1998-04-27 |
2001-04-18 |
Pfizer Products Inc. |
7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors
|
DE19822198C2
(de)
|
1998-05-16 |
2003-02-13 |
Wella Ag |
Oxonolfarbstoffe enthaltende Mittel und Verfahren zur Erzeugung von semipermanenten Färbungen auf Haaren
|
KR20010052570A
(ko)
|
1998-06-04 |
2001-06-25 |
스티븐 에프. 웨인스톡 |
세포 유착을 억제하는 소염성 화합물
|
DE19826671A1
(de)
|
1998-06-16 |
1999-12-23 |
Hoechst Schering Agrevo Gmbh |
1,3-Oxazolin- und 1,3-Thiazolin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
|
FR2781218B1
(fr)
|
1998-07-15 |
2001-09-07 |
Lafon Labor |
Compositions pharmaceutiques comprenant des 2-quinolones
|
JP2000072731A
(ja)
|
1998-08-31 |
2000-03-07 |
Taisho Pharmaceut Co Ltd |
4−置換−2−アミノビシクロ[3.1.0]ヘキサン−2,6−ジカルボン酸誘導体及び製薬用組成物
|
US6333428B1
(en)
|
1998-08-31 |
2001-12-25 |
Taisho Pharmaceutical Co., Ltd. |
6-fluorobicyclo[3.1.0]hexane derivatives
|
EP1109555A4
(en)
|
1998-08-31 |
2001-11-21 |
Merck & Co Inc |
NEW ANGIOGENIC INHIBITORS
|
CH694053A5
(de)
|
1998-09-03 |
2004-06-30 |
Hoffmann La Roche |
Verfahren zur Herstellung von 2-Amino-bicyclo[3.1.0]hexan-2,6-dicarbonsäure-Derivaten.
|
US6284759B1
(en)
|
1998-09-30 |
2001-09-04 |
Neurogen Corporation |
2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
|
SE9803518D0
(sv)
|
1998-10-15 |
1998-10-15 |
Astra Pharma Prod |
Novel compounds
|
PE20001236A1
(es)
|
1998-11-13 |
2000-11-10 |
Lilly Co Eli |
Moduladores del receptor de aminoacidos excitadores
|
US6133271A
(en)
|
1998-11-19 |
2000-10-17 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
|
US5948911A
(en)
|
1998-11-20 |
1999-09-07 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to thienopyrimidine derivatives
|
EP1006112A1
(en)
|
1998-12-01 |
2000-06-07 |
Cerebrus Pharmaceuticals Limited |
3-Hydroxy-2(1H)-pyridinone or 3-hydroxy-4(1H)-pyridinone derivatives useful as reactive oxygen species (ROS) scavengers
|
ES2281975T3
(es)
|
1998-12-04 |
2007-10-01 |
Bristol-Myers Squibb Company |
Derivados 3-sustituidos de 4-arilquinolin-2-ona como moduladores de los canales de potasio.
|
US6245759B1
(en)
|
1999-03-11 |
2001-06-12 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
TW564247B
(en)
|
1999-04-08 |
2003-12-01 |
Akzo Nobel Nv |
Bicyclic heteraromatic compound
|
GB9908175D0
(en)
|
1999-04-09 |
1999-06-02 |
Lilly Co Eli |
Method of treating neurological disorders
|
US6723711B2
(en)
|
1999-05-07 |
2004-04-20 |
Texas Biotechnology Corporation |
Propanoic acid derivatives that inhibit the binding of integrins to their receptors
|
US6972296B2
(en)
|
1999-05-07 |
2005-12-06 |
Encysive Pharmaceuticals Inc. |
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
|
WO2000069816A1
(en)
|
1999-05-17 |
2000-11-23 |
Eli Lilly And Company |
Metabotropic glutamate receptor antagonists
|
EP1595871A3
(en)
|
1999-06-02 |
2005-11-30 |
Nps Pharmaceuticals, Inc. |
Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
|
US6498180B1
(en)
|
1999-06-03 |
2002-12-24 |
Eli Lilly And Company |
Excitatory amino acid receptor modulators
|
JP4783967B2
(ja)
|
1999-07-21 |
2011-09-28 |
大正製薬株式会社 |
含フッ素アミノ酸誘導体を有効成分とする医薬
|
WO2001010846A2
(en)
|
1999-08-05 |
2001-02-15 |
Igt Pharma Inc. |
1,4-diazepine derivatives for the treatment of diseases related to the central nervous system
|
US6660753B2
(en)
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
US7040838B2
(en)
|
1999-08-27 |
2006-05-09 |
Kristar Enterprises, Inc. |
High capacity catch basin filtration system with adjustable deflector ring
|
TR200201023T2
(tr)
|
1999-10-15 |
2002-09-23 |
F. Hoffmann-La Roche Ag |
Benzodiazepin türevleri.
|
CA2386980C
(en)
|
1999-10-15 |
2010-03-16 |
Geo Adam |
Benzodiazepine derivatives for use in acute or chronic neurological disorders
|
KR100681724B1
(ko)
|
1999-10-19 |
2007-02-28 |
머크 앤드 캄파니 인코포레이티드 |
티로신 키나제 억제제 및 이를 포함하는 약제학적 조성물
|
SV2002000205A
(es)
|
1999-11-01 |
2002-06-07 |
Lilly Co Eli |
Compuestos farmaceuticos ref. x-01095
|
GB2355982A
(en)
|
1999-11-03 |
2001-05-09 |
Lilly Co Eli |
Heterocyclic amino acids
|
AU2220801A
(en)
|
1999-12-22 |
2001-07-03 |
Kyorin Pharmaceutical Co. Ltd. |
Tricyclic compounds and addition salts thereof
|
GB0002100D0
(en)
|
2000-01-28 |
2000-03-22 |
Novartis Ag |
Organic compounds
|
US6800651B2
(en)
|
2000-02-03 |
2004-10-05 |
Eli Lilly And Company |
Potentiators of glutamate receptors
|
YU63802A
(sh)
|
2000-02-25 |
2005-06-10 |
F. Hoffmann-La Roche Ag. |
Modulatori adenozinskih receptora
|
DE10012373A1
(de)
|
2000-03-14 |
2001-09-20 |
Dresden Arzneimittel |
Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion
|
GB0007108D0
(en)
|
2000-03-23 |
2000-05-17 |
Novartis Ag |
Organic compounds
|
US6469026B2
(en)
|
2000-03-24 |
2002-10-22 |
Millennium Pharmaceuticals, Inc. |
Isoquinolone inhibitors of factor Xa
|
GB0007193D0
(en)
|
2000-03-25 |
2000-05-17 |
Univ Manchester |
Treatment of movrmrnt disorders
|
CN1173975C
(zh)
|
2000-04-27 |
2004-11-03 |
山之内制药株式会社 |
咪唑并吡啶衍生物
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
TWI282786B
(en)
|
2000-04-28 |
2007-06-21 |
Nihon Nohyaku Co Ltd |
A process for preparing 2-halogenobenzoic acids
|
WO2001083431A1
(fr)
|
2000-04-28 |
2001-11-08 |
Shionogi & Co., Ltd. |
Inhibiteurs de mmp-12
|
WO2001085716A1
(en)
|
2000-05-11 |
2001-11-15 |
Kyowa Hakko Kogyo Co., Ltd |
2-piperidone compounds for the treatment of cancer
|
EP1280760B1
(en)
|
2000-05-11 |
2004-04-28 |
Kenneth Curry |
Novel spiro[2.4]heptane amino carboxy compounds and derivatives thereof
|
US20020009713A1
(en)
|
2000-05-11 |
2002-01-24 |
Miller Freda D. |
Methods for identifying modulators of neuronal growth
|
US7081481B2
(en)
|
2000-05-31 |
2006-07-25 |
Eli Lilly And Company |
Excitatory amino acid receptor modulators
|
NZ522773A
(en)
|
2000-06-12 |
2005-06-24 |
Eisai Co Ltd |
1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
|
AU2001276610A1
(en)
|
2000-06-27 |
2002-01-08 |
Centre National De La Recherche Scientifique-Cnrs |
Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof
|
JP2002012533A
(ja)
|
2000-06-27 |
2002-01-15 |
Kao Corp |
染毛剤組成物
|
JP2002003401A
(ja)
|
2000-06-27 |
2002-01-09 |
Japan Science & Technology Corp |
脳由来神経栄養因子誘導剤
|
AU6785401A
(en)
|
2000-06-28 |
2002-01-08 |
Taisho Pharmaceutical Co Ltd |
Novel dicarboxylic acid derivatives
|
DE10031390A1
(de)
|
2000-07-03 |
2002-01-17 |
Knoll Ag |
Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
|
US20020041880A1
(en)
|
2000-07-05 |
2002-04-11 |
Defeo-Jones Deborah |
Method of treating cancer
|
JP2002069057A
(ja)
|
2000-07-07 |
2002-03-08 |
Kyowa Hakko Kogyo Co Ltd |
ピペリジン誘導体
|
JP2002040252A
(ja)
|
2000-07-27 |
2002-02-06 |
Shiseido Co Ltd |
コレステリック液晶層を含む光学シート、それを用いた情報記録体、情報記録方法並びに情報判別方法
|
DE10038019A1
(de)
|
2000-08-04 |
2002-02-14 |
Bayer Ag |
Substituierte Triazolopyrid(az)ine
|
EP1849782A1
(en)
|
2000-09-11 |
2007-10-31 |
Novartis Vaccines and Diagnostics, Inc. |
Quinolinone derivatives as tyrosine kinase inhibitors
|
WO2002022622A2
(en)
|
2000-09-13 |
2002-03-21 |
Georgetown University |
Synthesis of 2-hydroxymethylglutamic acid and congeners thereof
|
JP2002105085A
(ja)
|
2000-09-28 |
2002-04-10 |
Yamanouchi Pharmaceut Co Ltd |
新規イミダゾチアゾール誘導体
|
CN1703403A
(zh)
|
2000-10-02 |
2005-11-30 |
詹森药业有限公司 |
趋代谢的谷氨酸盐受体拮抗剂
|
DE10058663A1
(de)
|
2000-11-25 |
2002-05-29 |
Merck Patent Gmbh |
Verwendung von Thienopyrimidinen
|
WO2002051849A1
(fr)
|
2000-12-26 |
2002-07-04 |
Daiichi Pharmaceutical Co., Ltd. |
Inhibiteurs cdk4
|
JP2002308882A
(ja)
|
2001-02-08 |
2002-10-23 |
Yamanouchi Pharmaceut Co Ltd |
チエノピリミジン誘導体
|
WO2002064096A2
(en)
|
2001-02-16 |
2002-08-22 |
Tularik Inc. |
Methods of using pyrimidine-based antiviral agents
|
ES2360205T3
(es)
|
2001-03-02 |
2011-06-01 |
Agennix Ag |
Sistema de ensayo de tres híbridos.
|
WO2002074025A2
(de)
|
2001-03-08 |
2002-09-19 |
Ilfa Industrieelektronik Und Leiterplattenfertigung Aller Art Gmbh |
Mehrschichtige leiterplatte
|
US6596731B2
(en)
|
2001-03-27 |
2003-07-22 |
Hoffmann-La Roche Inc. |
Substituted imidazo[1,2-A] pyridine derivatives
|
JP2004527244A
(ja)
|
2001-04-02 |
2004-09-09 |
メルク エンド カムパニー インコーポレーテッド |
受容体型キナーゼ阻害剤の活性のインビボ測定方法
|
ES2246012T3
(es)
|
2001-04-12 |
2006-02-01 |
F. Hoffmann-La Roche Ag |
Derivados de dihidro benzo(b) (1,4)diacepin-2-ona como antagonistas de mglur2 ii.
|
BR0208887A
(pt)
|
2001-04-12 |
2004-06-29 |
Hoffmann La Roche |
Derivados de dihidro-benzo[b][1,4]diazepin-2-ona como antagonistas i de mglur2
|
SE0101579D0
(sv)
|
2001-05-04 |
2001-05-04 |
Astrazeneca Ab |
New compounds
|
SK13752003A3
(en)
|
2001-05-14 |
2004-11-03 |
Bristol Myers Squibb Pharma Co |
Substituted pyrazinones, pyridines and pyrimidines as ligands of factor releasing corticotropine
|
US7144903B2
(en)
|
2001-05-23 |
2006-12-05 |
Amgen Inc. |
CCR4 antagonists
|
JP2004532250A
(ja)
|
2001-05-30 |
2004-10-21 |
アルテオン インコーポレイテッド |
線維性疾患又は他の適応症の治療方法
|
US6806268B2
(en)
|
2001-05-30 |
2004-10-19 |
Alteon, Inc. |
Method for treating glaucoma V
|
ATE338035T1
(de)
|
2001-06-05 |
2006-09-15 |
Boehringer Ingelheim Pharma |
1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
|
WO2002102807A1
(fr)
|
2001-06-14 |
2002-12-27 |
Banyu Pharmaceutical Co., Ltd. |
Nouveaux derives d'isoxazolopyridone et leur utilisation
|
WO2002102313A2
(en)
|
2001-06-19 |
2002-12-27 |
Bristol-Myers Squibb Company |
Pyrimidine inhibitors of phosphodiesterase (pde) 7
|
JP2003012653A
(ja)
|
2001-06-28 |
2003-01-15 |
Yamanouchi Pharmaceut Co Ltd |
キナゾリン誘導体
|
EP1411941A2
(en)
|
2001-08-02 |
2004-04-28 |
Neurocrine Biosciences, Inc. |
Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
|
AU2002333524A1
(en)
|
2001-09-11 |
2003-03-24 |
Glaxosmithkline K.K. |
Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
|
AU2002341920A1
(en)
|
2001-10-02 |
2003-04-14 |
Smithkline Beecham Corporation |
Chemical compounds
|
TWI330183B
(pt)
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
TW200406466A
(en)
|
2001-11-13 |
2004-05-01 |
Ciba Sc Holding Ag |
Compositions comprising at least one oxonol dye and at least one metal complex
|
US6921762B2
(en)
|
2001-11-16 |
2005-07-26 |
Amgen Inc. |
Substituted indolizine-like compounds and methods of use
|
GB0129260D0
(en)
|
2001-12-06 |
2002-01-23 |
Eisai London Res Lab Ltd |
Pharmaceutical compositions and their uses
|
JP2005518377A
(ja)
|
2001-12-14 |
2005-06-23 |
ノボ ノルディスク アクティーゼルスカブ |
ホルモン感受性リパーゼの活性を低下させるための化合物の使用
|
EP1465869B1
(en)
|
2001-12-21 |
2013-05-15 |
Exelixis Patent Company LLC |
Modulators of lxr
|
DE10164139A1
(de)
|
2001-12-27 |
2003-07-10 |
Bayer Ag |
2-Heteroarylcarbonsäureamide
|
RU2315622C2
(ru)
|
2001-12-27 |
2008-01-27 |
Тайсо Фармасьютикал Ко.,Лтд. |
Производные 6-фторбицикло[3.1.0]гексана
|
JP2005170790A
(ja)
|
2002-01-09 |
2005-06-30 |
Ajinomoto Co Inc |
N−アルキルスルフォニル置換アミド誘導体
|
JP2005515254A
(ja)
|
2002-01-17 |
2005-05-26 |
スミスクライン ビーチャム コーポレーション |
カテプシンk阻害剤として有用なシクロアルキルケトアミド誘導体
|
US20050113283A1
(en)
|
2002-01-18 |
2005-05-26 |
David Solow-Cordero |
Methods of treating conditions associated with an EDG-4 receptor
|
EP1513522A2
(en)
|
2002-01-18 |
2005-03-16 |
Sri International |
Methods of treating conditions associated with an edg receptor
|
WO2003064428A1
(en)
|
2002-01-29 |
2003-08-07 |
H. Lundbeck A/S |
Furano- and thienopyrimidines as neurokinase inhibitors
|
US6949542B2
(en)
|
2002-02-06 |
2005-09-27 |
Hoffman-La Roche Inc. |
Dihydro-benzo[b][1,4]diazepin-2-one derivatives
|
KR20040101220A
(ko)
|
2002-02-07 |
2004-12-02 |
더 유니버시티 오브 마이애미 |
중추신경계 신경 재생을 촉진하는 슈반 세포 브리지임플란트 및 포스포디에스테라제 저해제
|
US20040116489A1
(en)
|
2002-02-12 |
2004-06-17 |
Massey Steven Marc |
Synthetic excitatory amino acids
|
AU2003211931A1
(en)
|
2002-02-13 |
2003-09-04 |
Takeda Chemical Industries, Ltd. |
Jnk inhibitor
|
PL218749B1
(pl)
|
2002-02-14 |
2015-01-30 |
Pharmacia Corp |
Pochodna pirydynonu oraz jej zastosowanie do wytwarzania leku
|
WO2003070712A1
(en)
|
2002-02-19 |
2003-08-28 |
H. Lundbeck A/S |
Thioibotenic acid and derivatives thereof
|
US6833380B2
(en)
|
2002-03-07 |
2004-12-21 |
Warner-Lambert Company, Llc |
Compounds that modulate PPAR activity and methods of preparation
|
EP1487794A1
(en)
|
2002-03-14 |
2004-12-22 |
Bayer Aktiengesellschaft |
Monocyclic aroylpyridinones as antiinflammatory agents
|
US7271266B2
(en)
|
2002-03-28 |
2007-09-18 |
Merck & Co., Inc. |
Substituted 2,3-diphenyl pyridines
|
CA2479109C
(en)
|
2002-03-29 |
2011-08-02 |
Janssen Pharmaceutica N.V. |
Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
|
WO2003084610A1
(en)
|
2002-04-03 |
2003-10-16 |
Eli Lilly And Company |
Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
|
WO2003092595A2
(en)
|
2002-05-02 |
2003-11-13 |
Merck & Co., Inc |
Tyrosine kinase inhibitors
|
US6864261B2
(en)
|
2002-05-02 |
2005-03-08 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
US7026326B2
(en)
|
2002-05-21 |
2006-04-11 |
Amgen Inc. |
Substituted heterocyclic compounds and methods of use
|
CA2390348A1
(en)
|
2002-06-10 |
2003-12-10 |
Ibm Canada Limited-Ibm Canada Limitee |
Systems, methods and computer programs for implementing and accessing webservices
|
KR20080058509A
(ko)
|
2002-06-11 |
2008-06-25 |
일라이 릴리 앤드 캄파니 |
흥분성 아미노산의 전구약물
|
ES2277088T3
(es)
|
2002-06-13 |
2007-07-01 |
Vertex Pharmaceuticals Incorporated |
Derivados del acido 2-ureido-6-heteroaril-3h-benzoimidazol-4-carboxilico y compuestos relacionados como inhibidores de girasa y/o topoisomerasa iv para el tratamiento de infecciones bacterianas.
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
GB0214268D0
(en)
|
2002-06-20 |
2002-07-31 |
Celltech R&D Ltd |
Chemical compounds
|
EP1545523A1
(en)
|
2002-07-03 |
2005-06-29 |
Astex Technology Limited |
3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS
|
US7262194B2
(en)
|
2002-07-26 |
2007-08-28 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
US20040138238A1
(en)
|
2002-08-08 |
2004-07-15 |
Dhanoa Dale S. |
Substituted aminopyrimidine compounds as neurokinin antagonists
|
GB0218630D0
(en)
|
2002-08-10 |
2002-09-18 |
Tanabe Seiyaku Co |
Novel compounds
|
GB0218800D0
(en)
|
2002-08-13 |
2002-09-18 |
Celltech R&D Ltd |
Chemical compounds
|
WO2004017950A2
(en)
|
2002-08-22 |
2004-03-04 |
Piramed Limited |
Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents
|
WO2004018386A2
(en)
|
2002-08-26 |
2004-03-04 |
Merck & Co., Inc. |
Acetophenone potentiators of metabotropic glutamate receptors
|
EP1551369A4
(en)
|
2002-08-28 |
2007-05-09 |
Intermune Inc |
COMBINATION THERAPY FOR THE TREATMENT OF FIBROTIC DISEASES
|
MY139563A
(en)
|
2002-09-04 |
2009-10-30 |
Bristol Myers Squibb Co |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
ES2381664T3
(es)
|
2002-09-10 |
2012-05-30 |
Novartis Ag |
Combinaciones de antagonistas del receptor metabotrópico de glutamato y su uso en el tratamiento de trastornos adictivos
|
CA2497356A1
(en)
|
2002-09-11 |
2004-03-25 |
Merck & Co., Inc. |
Nucleic acid sequences encoding novel point mutations on mglur2 and mglur3
|
EP1554276B1
(en)
|
2002-09-19 |
2006-06-28 |
Boehringer Ingelheim (Canada) Ltd. |
Non-nucleoside reverse transcriptase inhibitors
|
EP1543006A1
(en)
|
2002-09-19 |
2005-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Non-nucleoside reverse transcriptase inhibitors
|
AR044743A1
(es)
|
2002-09-26 |
2005-10-05 |
Nihon Nohyaku Co Ltd |
Herbicida, metodo de emplearlo, derivados de tienopirimidina sustituida,compuestos intermediarios, y procedimientos que se utilizan para producirlos,
|
US7067658B2
(en)
|
2002-09-30 |
2006-06-27 |
Bristol-Myers Squibb Company |
Pyridino and pyrimidino pyrazinones
|
US7998163B2
(en)
|
2002-10-03 |
2011-08-16 |
Boston Scientific Scimed, Inc. |
Expandable retrieval device
|
ATE450619T1
(de)
|
2002-10-23 |
2009-12-15 |
Daiichi Pure Chemicals Co Ltd |
Defructosylierungsverfahren
|
US20040138204A1
(en)
|
2002-10-30 |
2004-07-15 |
Harrington James Frederick |
Compositions and methods for pain reduction
|
PL376823A1
(pl)
|
2002-11-01 |
2006-01-09 |
Abbott Laboratories |
Środki przeciwzakaźne
|
US7902203B2
(en)
|
2002-11-01 |
2011-03-08 |
Abbott Laboratories, Inc. |
Anti-infective agents
|
US6930117B2
(en)
|
2002-11-09 |
2005-08-16 |
The Procter & Gamble Company |
N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
|
KR101052482B1
(ko)
|
2002-11-21 |
2011-07-28 |
노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 |
포스포티딜이노시톨(pi) 3-키나제 억제제인 2,4,6-삼치환피리미딘 및 암의 치료에서 이들의 사용
|
WO2004054979A1
(ja)
|
2002-12-18 |
2004-07-01 |
Takeda Pharmaceutical Company Limited |
Jnk阻害剤
|
CN1802353A
(zh)
|
2002-12-30 |
2006-07-12 |
细胞基因公司 |
氟烷氧基取代的1,3-二氢-异吲哚化合物及其药物用途
|
ATE374766T1
(de)
|
2003-01-14 |
2007-10-15 |
Arena Pharm Inc |
1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie
|
ITMI20030151A1
(it)
|
2003-01-30 |
2004-07-31 |
Recordati Ind Chimica E Farma Ceutica S P A |
Uso di antagonisti selettivi del recettore mglu5 per il trattamento di disfunzioni neuromuscolari del tratto urinario inferiore.
|
NZ541324A
(en)
|
2003-02-04 |
2008-10-31 |
Hoffmann La Roche |
Malonamide derivatives as gamma-secretase inhibitors
|
DE10306250A1
(de)
|
2003-02-14 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
ES2316964T3
(es)
|
2003-02-24 |
2009-04-16 |
Arena Pharmaceuticals, Inc. |
Fenil-y piridilpipereidinia-derivados como moduladores del metabolismo de la glucosa.
|
ES2297386T3
(es)
|
2003-03-03 |
2008-05-01 |
F. Hoffmann-La Roche Ag |
Tetrahidroisoquinolinas 2,5-sustituidas para uso como moduladores de 5-ht6.
|
ITFI20030058A1
(it)
|
2003-03-06 |
2004-09-07 |
Univ Firenze |
Formulazioni farmaceutiche contenenti tiazolidinedioni
|
DE10311065A1
(de)
|
2003-03-13 |
2004-09-23 |
Abbott Gmbh & Co. Kg |
Pyrimidin-2-on-Verbindungen und ihre therapeutische Verwendung
|
WO2004092123A2
(en)
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
JP2006523707A
(ja)
|
2003-04-15 |
2006-10-19 |
アストラゼネカ アクツィエボラーグ |
治療化合物
|
JP2004339080A
(ja)
|
2003-05-13 |
2004-12-02 |
Tokyo Institute Of Technology |
ピラゾ−ル誘導体を含有する高血圧治療剤
|
JP4847868B2
(ja)
|
2003-05-14 |
2011-12-28 |
ニューロジェネティック ファーマシューティカルズ、 インコーポレイテッド |
化合物、及び、アミロイドベータの調節におけるその使用
|
US20070053831A1
(en)
|
2003-05-20 |
2007-03-08 |
Barrio Jorge R |
Methods for binding agents to b-amyloid plaques
|
GB0315950D0
(en)
|
2003-06-11 |
2003-08-13 |
Xention Discovery Ltd |
Compounds
|
CA2572324A1
(en)
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
WO2005007144A2
(en)
|
2003-07-14 |
2005-01-27 |
Decode Genetics Ehf |
Method of diagnosis and treatment for asthma based on haplotype association
|
US7820658B2
(en)
|
2003-08-29 |
2010-10-26 |
Vernalis (Cambridge) Limited |
Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors
|
GB0320300D0
(en)
|
2003-08-29 |
2003-10-01 |
Cancer Rec Tech Ltd |
Pyrimidothiophene compounds
|
GB0322016D0
(en)
|
2003-09-19 |
2003-10-22 |
Merck Sharp & Dohme |
New compounds
|
AU2005214379B2
(en)
|
2004-02-18 |
2012-03-22 |
Astrazeneca Ab |
Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
|
DE102004009039A1
(de)
|
2004-02-23 |
2005-09-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und Verwendung als Arzneimittel
|
US7306631B2
(en)
|
2004-03-30 |
2007-12-11 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
TW200609237A
(en)
|
2004-04-12 |
2006-03-16 |
Sankyo Co |
Thienopyridine derivatives
|
US7459562B2
(en)
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
GB0413605D0
(en)
|
2004-06-17 |
2004-07-21 |
Addex Pharmaceuticals Sa |
Novel compounds
|
US8063004B2
(en)
|
2004-07-22 |
2011-11-22 |
Malcera, L.L.C. |
Chemical composition of matter for the liquefaction and dissolution of asphaltene and paraffin sludges into petroleum crude oils and refined products at ambient temperatures and method of use
|
AU2005267883A1
(en)
|
2004-07-30 |
2006-02-09 |
Merck & Co., Inc. |
Indanone potentiators of metabotropic glutamate receptors
|
CA2574956A1
(en)
|
2004-07-30 |
2006-02-09 |
Merck & Co., Inc. |
Heterocyclic acetophenone potentiators of metabotropic glutamate receptors
|
US20080051409A1
(en)
|
2004-08-02 |
2008-02-28 |
Peter Gmeiner |
Indolizine Carboxamides and Aza and Diaza Derivatives Thereof
|
JP5276322B2
(ja)
|
2004-08-11 |
2013-08-28 |
コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ |
虚血性心疾患の超音波診断方法及び装置
|
TW200613272A
(en)
|
2004-08-13 |
2006-05-01 |
Astrazeneca Ab |
Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
|
JP2008509985A
(ja)
|
2004-08-18 |
2008-04-03 |
ファルマシア アンド アップジョン カンパニー リミテッド ライアビリティ カンパニー |
炎症治療用の新規トリアゾロピリジン化合物
|
DE102004044884A1
(de)
|
2004-09-14 |
2006-05-24 |
Grünenthal GmbH |
Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
CN101048157A
(zh)
|
2004-10-25 |
2007-10-03 |
默克公司 |
代谢型谷氨酸受体的杂环二氢茚酮增强剂
|
ES2333979T3
(es)
|
2004-11-22 |
2010-03-03 |
Eli Lilly And Company |
Potenciadores de los receptores del glutamato.
|
US7434262B2
(en)
|
2004-12-08 |
2008-10-07 |
At&T Intellectual Property I, L.P. |
Methods and systems that selectively resurrect blocked communications between devices
|
DE102004061288A1
(de)
|
2004-12-14 |
2006-06-29 |
Schering Ag |
3-Amino-Pyrazolo[3,4b]pyridine als Inhibitoren von Proteintyrosinkinasen, deren Herstellung und Verwendung als Arzneimittel
|
CN101128435A
(zh)
|
2004-12-27 |
2008-02-20 |
阿斯利康(瑞典)有限公司 |
作为代谢型谷氨酸受体激动剂用于治疗神经病学及精神病学病症的吡唑酮化合物
|
US7456289B2
(en)
|
2004-12-31 |
2008-11-25 |
National Health Research Institutes |
Anti-tumor compounds
|
JP2008536802A
(ja)
|
2005-02-24 |
2008-09-11 |
メルク エンド カムパニー インコーポレーテッド |
代謝調節型グルタミン酸受容体のベンズアゾール増強剤
|
PT1863818E
(pt)
|
2005-03-23 |
2010-04-09 |
Hoffmann La Roche |
Derivados de acetilenil-pirazolo-pirimidina como antagonistas de mglur2
|
AP2007004198A0
(en)
*
|
2005-04-08 |
2007-10-31 |
Pfizer Prod Inc |
Bicyclic [3.1.0] heteroaryl amides as type I glycine transport inhibitors
|
US7572807B2
(en)
|
2005-06-09 |
2009-08-11 |
Bristol-Myers Squibb Company |
Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
|
US7579360B2
(en)
|
2005-06-09 |
2009-08-25 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
WO2006137350A1
(ja)
*
|
2005-06-22 |
2006-12-28 |
Kissei Pharmaceutical Co., Ltd. |
新規なフロピリジン誘導体、それを含有する医薬組成物およびそれらの用途
|
CA2616020A1
(en)
|
2005-08-05 |
2007-02-15 |
Astrazeneca Ab |
Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators
|
EP1912940A1
(en)
|
2005-08-12 |
2008-04-23 |
AstraZeneca AB |
Substituted isoindolones and their use as metabotropic glutamate receptor potentiators
|
WO2007027669A1
(en)
|
2005-08-29 |
2007-03-08 |
Cps Biofuels, Inc. |
Improved biodiesel fuel, additives, and lubbricants
|
EP1764099A3
(en)
|
2005-09-17 |
2007-05-09 |
Speedel Experimenta AG |
Diaminoalcohol derivatives for the treatment of Alzheimer, malaria, HIV
|
ATE434617T1
(de)
|
2005-09-17 |
2009-07-15 |
Novartis Ag |
5-amino-4-hydroxy-7-(imidazo ä1,2-aü pyridin-6- ylmethyl)-8-methylnonamidderivate und verwandte verbindungen als renininhibitoren zur behandlung von bluthochdruck
|
US8492428B2
(en)
|
2005-09-20 |
2013-07-23 |
Mayo Foundation For Medical Education And Research |
Small-molecule botulinum toxin inhibitors
|
KR101121292B1
(ko)
|
2005-09-27 |
2012-04-13 |
에프. 호프만-라 로슈 아게 |
Mglur2 길항제로서 옥사다이아졸일 피라졸로-피리미딘
|
EP1971601B1
(en)
|
2005-11-15 |
2009-10-21 |
Array Biopharma Inc. |
N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
|
TW200732313A
(en)
|
2005-12-15 |
2007-09-01 |
Astrazeneca Ab |
Oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
|
TW200804281A
(en)
|
2006-02-16 |
2008-01-16 |
Astrazeneca Ab |
New metabotropic glutamate receptor-potentiating isoindolones
|
EP1993539A4
(en)
|
2006-03-02 |
2010-05-19 |
Glaxosmithkline Llc |
THIAZOLONE AS A PI3 KINASE INHIBITOR
|
AR059898A1
(es)
|
2006-03-15 |
2008-05-07 |
Janssen Pharmaceutica Nv |
Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
|
GB0606774D0
(en)
|
2006-04-03 |
2006-05-10 |
Novartis Ag |
Organic compounds
|
GB0608263D0
(en)
|
2006-04-26 |
2006-06-07 |
Glaxo Group Ltd |
Compounds
|
WO2007135527A2
(en)
*
|
2006-05-23 |
2007-11-29 |
Pfizer Products Inc. |
Benzimidazolyl compounds
|
WO2007135529A2
(en)
*
|
2006-05-23 |
2007-11-29 |
Pfizer Products Inc. |
Azabenzimidazolyl compounds as mglur2 potentiators
|
US7879837B2
(en)
|
2006-06-19 |
2011-02-01 |
Toray Industries, Inc. |
Therapeutic or prophylactic agent for multiple sclerosis
|
WO2008006540A1
(en)
|
2006-07-12 |
2008-01-17 |
Syngenta Participations Ag |
Triazolopyridine derivatives as herbicides
|
PE20080403A1
(es)
|
2006-07-14 |
2008-04-25 |
Amgen Inc |
Derivados heterociclicos fusionados y metodos de uso
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
WO2008012622A2
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
WO2008012623A1
(en)
|
2006-07-25 |
2008-01-31 |
Pfizer Products Inc. |
Benzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
|
EP2061775A2
(en)
|
2006-09-13 |
2009-05-27 |
Astra Zeneca AB |
Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
|
AU2007307031B2
(en)
|
2006-10-11 |
2011-11-24 |
Amgen Inc. |
Imidazo- and triazolo-pyridine compounds and methods of use therof
|
WO2008057855A2
(en)
|
2006-11-01 |
2008-05-15 |
Bristol-Myers Squibb Company |
Heterocyclic compounds as modulators of glucocorticoid receptor, ap-i, and/or np-kappa-b activity
|
TW200831085A
(en)
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Non-nucleoside reverse transcriptase inhibitors
|
JP5442448B2
(ja)
|
2006-12-22 |
2014-03-12 |
アステックス、セラピューティックス、リミテッド |
Fgfrインヒビターとしての二環式ヘテロ環式化合物
|
EP2121687B1
(en)
|
2006-12-22 |
2015-10-14 |
Astex Therapeutics Limited |
Tricyclic amine derivatives as protein tyrosine kinase inhibitors
|
US20110053953A1
(en)
|
2007-02-09 |
2011-03-03 |
Abdelmalik Slassi |
AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613
|
ES2320955B1
(es)
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
GB0704407D0
(en)
|
2007-03-07 |
2007-04-18 |
Glaxo Group Ltd |
Compounds
|
BRPI0808445A2
(pt)
|
2007-03-07 |
2014-08-05 |
Janssen Pharmaceutica Nv |
TIAZOLIDINADIONAS COMO MODULADORES DE RECEPTOR-a RELACIONADOS COM ESTROGÊNIO
|
PT2132188E
(pt)
|
2007-03-07 |
2012-02-13 |
Janssen Pharmaceutica Nv |
Tiazolidinedionas n-alquiladas fenoxi substituídas como moduladores de receptores-alfa de estrogénio
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
AU2008222755B2
(en)
|
2007-03-07 |
2013-05-02 |
Janssen Pharmaceutica N.V. |
Substituted phenoxy aminothiazolones as estrogen related receptor-alpha modulators
|
TW200900391A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
|
NZ579431A
(en)
|
2007-03-09 |
2012-04-27 |
Sanofi Aventis |
Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
|
WO2008124085A2
(en)
|
2007-04-03 |
2008-10-16 |
Exelixis, Inc. |
Methods of using combinations of mek and jak-2 inhibitors
|
WO2008130853A1
(en)
|
2007-04-17 |
2008-10-30 |
Astrazeneca Ab |
Hydrazides and their use as metabotropic glutamate receptor potentiators - 681
|
EP2167464B1
(en)
|
2007-05-25 |
2014-12-03 |
AbbVie Deutschland GmbH & Co KG |
Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mglu2 receptor)
|
TW200911255A
(en)
|
2007-06-07 |
2009-03-16 |
Astrazeneca Ab |
Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators-841
|
TWI417100B
(zh)
|
2007-06-07 |
2013-12-01 |
Astrazeneca Ab |
二唑衍生物及其作為代謝型麩胺酸受體增效劑-842之用途
|
WO2009004430A1
(en)
|
2007-06-29 |
2009-01-08 |
Pfizer Inc. |
N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors
|
TWI475995B
(zh)
|
2007-09-14 |
2015-03-11 |
Janssen Pharmaceuticals Inc |
1’,3’-二取代-4-苯基-3,4,5,6-四氫-2h,1’h-〔1,4’〕聯吡啶基-2’-酮化物
|
EA019085B1
(ru)
|
2007-09-14 |
2014-01-30 |
Янссен Фармасьютикалз, Инк. |
1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны
|
JP5433579B2
(ja)
|
2007-09-14 |
2014-03-05 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド. |
1,3−二置換−4−フェニル−1h−ピリジン−2−オン
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
RU2492170C9
(ru)
|
2007-11-14 |
2013-12-27 |
Орто-Макнейл-Янссен Фармасьютикалз, Инк. |
Имидазо[1,2-а]пиридиновые производные и их применение в качестве положительных аллостерических модуляторов рецепторов mglur2
|
JP2011510083A
(ja)
|
2008-01-24 |
2011-03-31 |
メルク・シャープ・エンド・ドーム・コーポレイション |
3,5−二置換−1,3−オキサゾリジン−2−オン誘導体
|
EP2268645B1
(en)
|
2008-03-06 |
2014-11-12 |
Sanofi |
Substituted dihydro, trihydro and tetrahydro cycloalkyloxazolopyrimidinones, preparation and use thereof as allosteric modulators of mglur
|
DE102008001056A1
(de)
|
2008-04-08 |
2009-10-15 |
Robert Bosch Gmbh |
Umlenkeinrichtung für einen Strahl einer elektromagnetischen Welle
|
JP2011520890A
(ja)
|
2008-05-15 |
2011-07-21 |
メルク・シャープ・エンド・ドーム・コーポレイション |
オキサゾロベンゾイミダゾール誘導体
|
CA2723729A1
(en)
|
2008-05-15 |
2009-11-19 |
Merck Sharp & Dohme Corp. |
Oxazolobenzimidazole derivatives
|
SA109300358B1
(ar)
|
2008-06-06 |
2012-11-03 |
استرازينيكا ايه بي |
مقويات مستقبل جلوتامات ذي انتحاء أيضي من أيزو إندولون
|
TW201006801A
(en)
|
2008-07-18 |
2010-02-16 |
Lilly Co Eli |
Imidazole carboxamides
|
UY32049A
(es)
|
2008-08-14 |
2010-03-26 |
Takeda Pharmaceutical |
Inhibidores de cmet
|
US8557809B2
(en)
|
2008-08-19 |
2013-10-15 |
Array Biopharma Inc. |
Triazolopyridine compounds as PIM kinase inhibitors
|
TWI496779B
(zh)
|
2008-08-19 |
2015-08-21 |
Array Biopharma Inc |
作為pim激酶抑制劑之三唑吡啶化合物
|
EP2344470B1
(en)
|
2008-09-02 |
2013-11-06 |
Janssen Pharmaceuticals, Inc. |
3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
|
EP2346505B1
(en)
|
2008-10-16 |
2014-04-23 |
Janssen Pharmaceuticals, Inc. |
Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
|
CA2744138C
(en)
|
2008-11-28 |
2015-08-11 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
AT507619B1
(de)
|
2008-12-05 |
2011-11-15 |
Oesterreichisches Forschungs Und Pruefzentrum Arsenal Ges M B H |
Verfahren zur approximation des zeitlichen verlaufs von verkehrsdaten
|
JP5679997B2
(ja)
|
2009-02-04 |
2015-03-04 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
|
WO2010114726A1
(en)
|
2009-03-31 |
2010-10-07 |
Merck Sharp & Dohme Corp. |
Aminobenzotriazole derivatives
|
EP2417135A1
(en)
|
2009-04-07 |
2012-02-15 |
Schering Corporation |
Substituted triazolopyridines and analogs thereof
|
AU2010246607B2
(en)
|
2009-05-12 |
2012-09-27 |
Addex Pharma S.A. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
JO2907B1
(en)
|
2009-05-12 |
2015-09-15 |
اديكس فرما اس ايه |
Pyridine derivatives 1, 2, 4 trisolo [4, 3-A] and their uses as positive LLs for 2MGLUR receptors
|
WO2010141360A1
(en)
|
2009-06-05 |
2010-12-09 |
Merck Sharp & Dohme Corp. |
Biaryl benzotriazole derivatives
|
US8975286B2
(en)
|
2009-08-20 |
2015-03-10 |
Merck Sharp & Dohme Corp. |
Ether benzotriazole derivatives
|
CN102002040A
(zh)
|
2009-09-01 |
2011-04-06 |
上海药明康德新药开发有限公司 |
一种三唑并吡啶环化合物的合成方法
|
AR078172A1
(es)
|
2009-09-15 |
2011-10-19 |
Sanofi Aventis |
Fenoximetil dihidro oxazolopirimidinonas sustituidas y uso de las mismas como moduladores de receptores metabotropicos de mglur
|
WO2011034741A1
(en)
|
2009-09-15 |
2011-03-24 |
Merck Sharp & Dohme Corp. |
Imidazopyridin-2-one derivatives
|
AR078173A1
(es)
|
2009-09-15 |
2011-10-19 |
Sanofi Aventis |
Bifeniloximetil dihidro oxazolopirimidinonas sustituidas, su preparacion y su uso
|
AR078171A1
(es)
|
2009-09-15 |
2011-10-19 |
Sanofi Aventis |
Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas
|
JP5204071B2
(ja)
|
2009-09-25 |
2013-06-05 |
パナソニック株式会社 |
電気かみそり
|
EP2496569A2
(en)
|
2009-11-02 |
2012-09-12 |
MSD Oss B.V. |
Heterocyclic derivatives
|
EP2542083B1
(en)
|
2010-03-04 |
2015-05-06 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of mglur2
|
WO2011116356A2
(en)
|
2010-03-19 |
2011-09-22 |
Sanford-Burnham Medical Research Institute |
Positive allosteric modulators of group ii mglurs
|
US8314120B2
(en)
|
2010-03-30 |
2012-11-20 |
Abbott Gmbh & Co. Kg |
Small molecule potentiators of metabotropic glutamate receptors
|
US8664214B2
(en)
|
2010-03-30 |
2014-03-04 |
AbbVie Deutschland GmbH & Co. KG |
Small molecule potentiators of metabotropic glutamate receptors I
|
EP2563143A4
(en)
|
2010-04-29 |
2013-09-25 |
Merck Sharp & Dohme |
SUBSTITUTED 1,3-BENZOTHIAZOL-2 (3H) -ONE AND [1,3-] THIAZOLO- [5,4-B] PYRIDINE-2 (-1H) -ONE AS POSITIVE ALLOSTERE MODULATORS OF MGLUR2
|
CA2795218A1
(en)
|
2010-04-30 |
2011-11-03 |
Helen Blade |
Polymorphs of a metabotropic glutamate receptor positive allosteric modulator
|
US8765784B2
(en)
|
2010-06-09 |
2014-07-01 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of MGLUR2
|
CN101893589B
(zh)
|
2010-06-29 |
2012-10-17 |
中国人民解放军第三0二医院 |
一种无菌检查方法及其使用的全封闭集菌安瓿培养器
|
WO2012021382A1
(en)
|
2010-08-12 |
2012-02-16 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of mglur2
|
US8785481B2
(en)
|
2010-09-29 |
2014-07-22 |
Merck Sharp & Dohme Corp. |
Ether benzotriazole derivatives
|
CA2814996C
(en)
|
2010-11-08 |
2019-10-01 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
JP5852666B2
(ja)
|
2010-11-08 |
2016-02-03 |
ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
|
EP2643320B1
(en)
|
2010-11-08 |
2015-03-04 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
CA2815120A1
(en)
|
2010-11-08 |
2012-05-18 |
Jose Ignacio Andres-Gil |
Radiolabelled mglur2 pet ligands
|
US20140088151A1
(en)
|
2011-05-03 |
2014-03-27 |
Douglas C. Beshore |
Alhydroxymethyl biaryl benzotriazole derivatives
|
US8772276B2
(en)
|
2011-05-03 |
2014-07-08 |
Merck Sharp & Dohme Corp. |
Alkyne benzotriazole derivatives
|
EP2704573A4
(en)
|
2011-05-03 |
2014-10-15 |
Merck Sharp & Dohme |
AMINOMETHYL biaryl BENZOTRIAZOL DERIVATIVES
|